C4 Therapeutics (CCCC) Accumulated Depreciation & Amortization: 2019-2025
Historic Accumulated Depreciation & Amortization for C4 Therapeutics (CCCC) over the last 5 years, with Sep 2025 value amounting to $460,000.
- C4 Therapeutics' Accumulated Depreciation & Amortization rose 4.07% to $460,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year increase of 18.31%. This contributed to the annual value of $9.2 million for FY2024, which is 18.97% up from last year.
- Latest data reveals that C4 Therapeutics reported Accumulated Depreciation & Amortization of $460,000 as of Q3 2025, which was down 25.20% from $615,000 recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Accumulated Depreciation & Amortization registered a high of $9.2 million during Q4 2024, and its lowest value of $442,000 during Q3 2024.
- For the 3-year period, C4 Therapeutics' Accumulated Depreciation & Amortization averaged around $3.3 million, with its median value being $460,000 (2025).
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first crashed by 94.78% in 2024, then skyrocketed by 37.28% in 2025.
- Over the past 5 years, C4 Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $6.9 million in 2021, then increased by 17.45% to $8.1 million in 2022, then dropped by 4.43% to $7.8 million in 2023, then grew by 18.97% to $9.2 million in 2024, then climbed by 4.07% to $460,000 in 2025.
- Its Accumulated Depreciation & Amortization was $460,000 in Q3 2025, compared to $615,000 in Q2 2025 and $456,000 in Q1 2025.